We therefore assessed p16INK4a, HPV–DNA and HPV genotypes in relation to tumour- and patient-related risk factors and survival in a cohort of more than 800 consecutively included OPSCC patients at a large German University Hospital diagnosed between 2000 and 2017. Here, CDKN2A is linked to neoplasm.